| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 582 | 333 | 55 |
| Full Text Views | 10 | 3 | 0 |
| PDF Downloads | 6 | 2 | 0 |
The Effect of Cycloguanil Pamoate (CI-501) Against a Chlorguanide-Resistant Chesson Strain of Plasmodium Vivax
William Chin
William Chin
Laboratory of Parasite Chemotherapy, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Malaria Project, U. S. Penitentiary, Atlanta, Georgia
Search for other papers by William Chin in
Current site
Google Scholar
PubMed
Search for other papers by William Chin in
Current site
Google Scholar
PubMed
Joseph S. Lunn
Joseph S. Lunn
Laboratory of Parasite Chemotherapy, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Malaria Project, U. S. Penitentiary, Atlanta, Georgia
Search for other papers by Joseph S. Lunn in
Current site
Google Scholar
PubMed
Search for other papers by Joseph S. Lunn in
Current site
Google Scholar
PubMed
Joel Buxbaum
Joel Buxbaum
Laboratory of Parasite Chemotherapy, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Malaria Project, U. S. Penitentiary, Atlanta, Georgia
Search for other papers by Joel Buxbaum in
Current site
Google Scholar
PubMed
Search for other papers by Joel Buxbaum in
Current site
Google Scholar
PubMed
Peter G. Contacos
Peter G. Contacos
Laboratory of Parasite Chemotherapy, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Malaria Project, U. S. Penitentiary, Atlanta, Georgia
Search for other papers by Peter G. Contacos in
Current site
Google Scholar
PubMed
Search for other papers by Peter G. Contacos in
Current site
Google Scholar
PubMed
Summary and Conclusions
A previously sensitive Chesson strain of Plasmodium vivax was made resistant to chlorguanide by the stepwise use of increasing subcurative dosages.
Two volunteers medicated with CI-501 (5 mg/kg body weight) two days before challenge, and an untreated control, were exposed to the bites of Anopheles quadrimaculatus infected with this resistant Chesson strain of P. vivax. The two medicated volunteers as well as the control developed infections with no significant differences in the prepatent period or the clinical course.
The results indicate that CI-501 has no demonstrable effect on the Chesson strain of P. vivax once resistance to the parent compound, chlorguanide, has been induced.
Author Notes
Present address: Department of Medicine, University Hospital, Syracuse, New York.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 582 | 333 | 55 |
| Full Text Views | 10 | 3 | 0 |
| PDF Downloads | 6 | 2 | 0 |